THOMBOPROPHYLAXIS IN MULTIPLE MYELOMA PATIENTS TREATED WITH LENALIDOMIDE OR THALIDOMIDE

被引：0
|
作者：
Palmaro, A. [1 ]
Despas, F. [1 ]
Lapeyre-Mestre, M. [1 ,2 ]
机构：
[1] CHU Toulouse, Univ Hosp, Med & Clin Pharmacol Unit, Toulouse, France
[2] Univ Toulouse, INSERM 1027, Pharmacoepidemiol Res Unit, Toulouse, France
来源：
CLINICAL THERAPEUTICS | 2015年 / 37卷 / 08期
关键词：
D O I：
10.1016/j.clinthera.2015.05.195
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E65 / E65
页数：1
相关论文
共 50 条
  • [21] The incidence of thromboembolism for lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma
    Ang Li
    Qian Wu
    Greg Warnick
    Shan Li
    Edward N. Libby
    David A. Garcia
    Gary H. Lyman
    Annals of Hematology, 2020, 99 : 121 - 126
  • [22] The Incidence of Thromboembolism for Lenalidomide Versus Thalidomide in Older Patients with Newly Diagnosed Multiple Myeloma
    Li, Ang
    Wu, Qian V.
    Warnick, Greg
    Libby, Edward N., III
    Garcia, David A.
    Lyman, Gary H.
    BLOOD, 2018, 132
  • [23] Thalidomide after lenalidomide: a possible treatment regimen in relapse refractory multiple myeloma patients
    Guglielmelli, Tommasina
    Petrucci, Maria Teresa
    Saglio, Giuseppe
    Palumbo, Antonio
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (01) : 108 - 110
  • [24] Elevated levels of Factor VIII in patients with multiple myeloma treated with thalidomide
    Cosmi, B.
    Legnani, C.
    Cini, M.
    Valdre, L.
    Palareti, G.
    THROMBOSIS RESEARCH, 2007, 120 : S152 - S153
  • [25] In vitro study of the hypercoagulable state in multiple myeloma patients treated or not with thalidomide
    Petropoulou, Anna D.
    Gerotziafas, Grigoris T.
    Samama, Meyer M.
    Hatmi, Mohamed
    Rendu, Francine
    Elalamy, Ismail
    THROMBOSIS RESEARCH, 2008, 121 (04) : 493 - 497
  • [26] Low incidence of thromboembolism in Korean patients with multiple myeloma treated with thalidomide
    Koh, Y.
    Bang, S.
    Lee, J.
    Yoon, H.
    Do, Y.
    Ryoo, H.
    Lee, N.
    Kim, S.
    Kim, K.
    Kim, H.
    Yoon, S.
    Won, J.
    Mun, Y.
    Lee, M.
    Rhee, K.
    Eom, H.
    Kim, M.
    Shin, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1100 - 1101
  • [27] FREQUENCY OF CYTOKINE PRODUCING MONOCYTES IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH THALIDOMIDE
    Filipe, S.
    Matos, A.
    Morgado, J. M.
    Silva, I.
    Inacio, M. J.
    Geraldes, C.
    Paiva, A.
    Pais, M. L.
    Teixeira, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 512 - 512
  • [28] A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in Taiwan
    Huang, Shang-Yi
    Yu, Yuan-Bin
    Yeh, Su-Peng
    Chen, Tsai-Yun
    Kao, Woei-Yau
    Chen, Chih-Cheng
    Chen, Tsai-Yun
    Kao, Woei-Yau
    Chen, Chih-Cheng
    Wang, Ming-Chung
    Lin, Hsuan-Yu
    Lin, Sheng-Fung
    Lin, Tseng-Hsi
    Hua, Ye
    Puccio-Pick, Marie
    DeMarco, Dena
    Jacques, Christian
    Dunn, Po
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2017, 116 (09) : 705 - 710
  • [29] Lenalidomide, melphalan, prednisone and thalidomide (RMPT) for relapsed/refractory multiple myeloma
    A Palumbo
    A Larocca
    P Falco
    G Sanpaolo
    A P Falcone
    V Federico
    L Canepa
    M Crugnola
    M Genuardi
    V Magarotto
    M T Petrucci
    M Boccadoro
    Leukemia, 2010, 24 : 1037 - 1042
  • [30] Lenalidomide, melphalan, prednisone and thalidomide (RMPT) for relapsed/refractory multiple myeloma
    Palumbo, A.
    Larocca, A.
    Falco, P.
    Sanpaolo, G.
    Falcone, A. P.
    Federico, V.
    Canepa, L.
    Crugnola, M.
    Genuardi, M.
    Magarotto, V.
    Petrucci, M. T.
    Boccadoro, M.
    LEUKEMIA, 2010, 24 (05) : 1037 - 1042
12345